secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2024-12-06T23:59:59+00:00
Accession:  0001753926-24-002047
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella Pharmaceuticals special meeting adjourned due to lack of quorum; reconvenes Dec 20
--------------------------------------------------------------------------------

- Lipella held special meeting Dec 6, 2024; no quorum present; meeting adjourned.
- Reconvened special meeting set for Dec 20, 2024 at 2:00 p.m. ET.
- Valid proxies from original meeting continue to apply unless changed or revoked.
- Meeting related to proposals in Definitive Proxy Statement filed Nov 12, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624002047/0001753926-24-002047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624002047/g084585_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-24-002047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer